Serpina3c inhibits the Hif1α-glycolysis pathway and reduces de novo lipogenesis and lactic acid secretion in adipocytes by binding to Nrf2, ultimately ameliorating obesity, hypertriglyceridemia, and metaflammation induced by HFD. The gene discussed is NFE2L2; the disease is Obesity.